Skip to main content

Table 3 Association between MALAT1 expression and RFS/DFS/DSS/PFS

From: Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis

Survival outcome Survival analysis Studies (n) Patients (n) HR (95% CI) P Heterogeneity (I2, P value)
RFS Univariate 5 397 1.355 (0.751–2.445) 0.313 70.6%, 0.009
Multivariate 3 263 2.491 (1.505–4.123) 0.000 0.0%, 0.435
DFS Univariate 1 77 1.820 (1.018–3.255) 0.044
Multivariate 3 329 2.036 (1.240–3.342) 0.005 32.7%, 0.226
DSS Univariate 3 2037 1.791 (1.304–2.459) 0.000 4.5%, 0.351
Multivariate 3 2037 2.098 (1.372–3.211) 0.001 0.0%, 0.578
PFS Univariate 1 100 3.03 (1.578–5.820) 0.001
Multivariate 2 175 1.842 (1.138–2.983) 0.013 0.0%, 0.940
  1. If I2 > 50%, the results were calculated by random model
  2. DFS disease-free survival, RFS recurrence-free survival, DSS disease-specific survival, PFS progression-free survival, HR hazard ratio, CI confidence interval